This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-Learn About Coagulation Disorders
-What are Bleeding Disorders?
 History of Bleeding Disorders
 Types of Bleeding Disorders
 Types of Bleeds
 Bleeding Disorders and Women
 Caring for the Newly Diagnosed Child
 Psychosocial Issues
-Complications, including Inhibitors
-For Consumers
 What is an Inhibitor?
 Who is at Risk for Developing an Inhibitor?
 How Do You Know If You Have an Inhibitor?
 Test Results
-Porcine Factor VIII
 Immune Tolerance
 Treatment Costs and Financial Considerations
 For Providers
 Discussion Group
 Future Therapies
 What are Clotting Disorders?
 Comprehensive Medical Care - Hemophilia Treatment Centers
 Medical and Scientific Advisory Council
 Financial and Insurance Issues
 HANDI, NHF's Information Resource Center
 Web Links



Porcine Factor VIII

Specifically for those people who have hemophilia A, the use of porcine factor VIII offers another therapeutic option. Porcine factor VIII, which is made from pig plasma, is similar enough to its human counterpart to work effectively in the human clotting system. However, it is different enough that inhibitors do not always recognize it to the same extent as they do the human factor VIII. This product has been shown to be effective in stopping major bleeds in patients whose inhibitor does not destroy porcine factor VIII. However, allergic side effects and a temporary drop in platelet counts can occur with the use of this product, which is limited to serious often life or limb threatening bleeding episodes. It is not used for routine treatment of bleeding episodes in inhibitor patients at home or in a clinic.




This section of our Web site is sponsored by: